Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s stock price shot up 1.1% on Thursday . The stock traded as high as $1.99 and last traded at $1.97. 5,721 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $1.95.
Ampliphi Biosciences Stock Performance
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
See Also
- Five stocks we like better than Ampliphi Biosciences
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What is Insider Trading? What You Can Learn from Insider Trading
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20211202075503&h=45&w=95&zc=2){kind=logo}
